TEVA Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Bank of America Merrill Lynch 2015 Health Care Conference. Eyal Desheh, Group EVP & CFO will present on Wednesday, May 13, 2015 at 3:40 PM PT.

    What: Teva Presentation at the Bank of America Merrill Lynch Healthcare Conference   Who: Eyal Desheh, Group EVP and CFO, Teva Pharmaceutical Industries Ltd.   When: Wednesday, May 13, 2015   Where: www.tevapharm.com   How: Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website .  

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com.

IR Contacts:Kevin C. Mannix, (215) 591-8912United StatesorRan Meir, (215) 591-3033United StatesorTomer Amitai, 972 (3) 926-7656IsraelorPR Contacts:Iris Beck Codner, 972 (3) 926-7246IsraelorDenise Bradley, (215) 591-8974United States